Clov Health retail shakeout, Wyckoff accumulation, and the impending recession/stagflation.

-6Hahpi_zWq9sKSpYpAE-48veSNLP80RkLgoW9xu

Hello Fellow Apes,

I know I haven’t posted much about $CLOV over the past few weeks, and I want to explain why. Lately, I’ve been stepping back to watch how the broader economy unfolds — and more importantly, I’ve been testing a thesis: I believe Clover is in the Wyckoff Accumulation phase.

Why do I think that?

Because I’ve started seeing articles and online chatter trying to paint $CLOV as a “bad investment” — right when it looks, fundamentally, like one of the most solid companies in our entire portfolio. That kind of negative press, especially when it’s not backed by real financial issues, often signals smart money trying to accumulate shares while retail sells out in fear.

Just to be clear: this is not financial advice.

In fact, over at Healthcare_Anon, we joke about our own positions all the time. One of our running lines is:

“You guys realize we’re the only idiots who don’t have SPY in our portfolio and we’re balls deep in a penny stock, right?”

Yeah — it’s funny because it’s true. But also… it’s not normal, and I want everyone here to really think about that. What we’re seeing with $CLOV doesn’t follow the usual retail trader narrative — and that’s exactly why I started looking at it through the Wyckoff lens.

What really got me thinking was when hit pieces on $CLOV started popping up right as the chart began showing signs of a breakout. That’s classic Wyckoff behavior — negative sentiment rising while smart money quietly buys in the background. Watching it unfold in real-time has been fascinating.

But to really follow what I’m talking about, you’ve got to understand what the Wyckoff Method is, and more specifically, how the accumulation cycle works. It’s not just technical analysis — it’s a way to read the intentions of institutional players and spot when a stock is being quietly loaded up before a big move.

https://finance.yahoo.com/news/q4-earnings-outperformers-clover-health-090348873.html

https://www.theglobeandmail.com/investing/markets/stocks/META-Q/pressreleases/31475771/3-reasons-clov-is-risky-and-1-stock-to-buy-instead/

The Wyckoff Method is a technical analysis framework developed by Richard D. Wyckoff in the early 1900s. It’s based on the idea that institutions (aka “smart money”) move markets in predictable ways — and that retail traders like us can spot those movements if we understand the signs.

The method focuses on three core elements:

  • Price action
  • Volume
  • The relationship between the two

Wyckoff believed that markets move through repeating four-phase cycles:

  1. Accumulation – smart money is buying
  2. Markup – price rises as demand overtakes supply
  3. Distribution – smart money is selling
  4. Markdown – price declines as supply overtakes demand

For our purposes, we’re going to zero in on the accumulation cycle — because that’s where I believe $CLOV is right now.

The accumulation phase happens after a long downtrend, when institutions begin quietly buying shares while retail sentiment is at its lowest. The goal? Accumulate large positions without driving the price up too quickly.

This phase often shows up as a sideways trading range, while the media is bearish, and retail investors are exhausted or scared off. In other words, it’s the perfect setup for smart money to buy while everyone else is giving up.

This is where Wyckoff shines: it helps us identify who’s in control — institutions or retail. It gives you context for fakeouts, breakouts, and reversals, and most importantly, it teaches you patience. You don’t chase price. You study the cycle and wait for confirmation.

There are 8 phases of the accumulation cycle.

  1. Preliminary Support (PS): The first sign of real buying interest after a long downtrend. Volume spikes as institutions start absorbing selling pressure.
  2. Selling Climax (SC): Panic selling hits its peak. Price drops hard, volume explodes — usually the highest of the whole range. This marks the emotional bottom.
  3. Automatic Rally (AR): A sharp bounce follows the SC as sellers dry up. Volume is still strong, but lower than during the climax. This rally defines the top of the range.
  4. Secondary Test (ST): Price retests the SC area to see if there’s any selling pressure left. Volume is typically lower than during the SC — a good sign that panic has cooled off.
  5. Spring (optional): A false breakdown below the SC. Price dips below support, triggering stop losses and trapping shorts. If volume surges here, it’s likely bait being taken. Smart money is loading up.
  6. Test: Price recovers above support, and volume drops off — confirming the spring was successful. No panic = no more sellers.
  7. Sign of Strength (SOS): Price breaks out above the AR resistance with strong volume and solid green candles. This confirms that buyers are in control.
  8. Last Point of Support (LPS): A shallow pullback occurs post-breakout. Volume is low on the dip, then builds again on the bounce. This is often the last chance to enter before full markup begins.

If you look at $CLOV’s price and volume behavior over the past six months, you can clearly see the anatomy of this pattern forming. I won’t rehash all the details from previous posts, but here’s the key point: the market has not priced in Clover’s upcoming catalysts — things like the 4-star Medicare rating and SaaS model are still flying under the radar.

https://preview.redd.it/ratt6wweoxre1.png?width=1868&format=png&auto=webp&s=bc89d2d42d8b9244850f11cd35682aa0eef7c82a

When these fundamental changes get recognized — and the accumulation phase ends — we could see a dramatic breakout in price. But timing that correctly is everything.

Here’s another piece of the puzzle: the shorts are back, using the fear of recession and stagflation as cover. You can see this by drawing Fibonacci retracement levels and comparing $CLOV to other healthcare names in the sector.

  • $CLOV has zero debt
  • It has an unaccounted 4-star rating
  • It’s transitioning to a high-margin SaaS model
  • It’s in a defensive sector (Medicare Advantage)
  • Its profit-per-member metrics are in another league

https://preview.redd.it/5bgi62thoxre1.png?width=955&format=png&auto=webp&s=81920765c966f19f48f339710863c28003c3f03a

https://preview.redd.it/3im75sthoxre1.png?width=955&format=png&auto=webp&s=8c1ea4ba482c4ea4f8009a553042887e90189a89

Yes, we’ve seen price and volume drop — but the intensity of shorting now is much weaker than what we saw last year. In other words, they’re running out of firepower.

If you’re long on $CLOV, here’s my take. Wait for confirmation that the accumulation cycle is complete. Don’t jump the gun — let the market show its hand. Be realistic about the macro environment. We could be entering a 2008-style recession — job losses, credit defaults, and a shrinking economy. This is not political. This is about preparing. In 2020, the world worked together to prevent a crash. This time, we’re talking about tariffs, taxation, and economic isolation.

Whether the market crashes or not is unknown — but you should be clear-eyed about the risk you’re taking.

Lastly, my thesis that Tesla is in the Wyckoff distribution phase is unfolding beautifully. Just look at that baby dive — classic distribution behavior. But that’s a post for another time 😉

submitted by /u/Rainyfriedtofu to r/Healthcare_Anon
[link] [comments]

SOURCE